Invasive Ductal Carcinoma - Fibroadenoma - TiCEM (USA)

64 year old lady. It was a second opinion from another center. The patient had a palpable mass and the biopsy was an invasive ductal cancer luminal a. This is the mission. One MRI performed in another center. See the index edition and. An additional enhancement muscle enhancement. In the same breast. There was no correlation with ultrasound. Then we perform a Tyson study. So we index lesion. But no additional enhancements. So there was a discordance between Tyson and MRI. We perform an MRI guided vacuum assisted biopsy of the additional lesion and the final result was a fibroadenoma. So. In conclusion, the additional lesion detected by MRI was a false positive. Result. And a two negative case for Tyson.

1/1/2022. 5:37 Preoperative 3 Digital Breast Tomosynthesis and Contrast Enhanced Mammography Prof. Dr. Luis Pina Breast Imaging Department (Radiología mamaria) Clínica Universidad de Navarra, Pamplona / Spain SIEMENS . 11_PreOP_3, PID3649 * 1/1/2022 F PID3649 LCC RMLO LMLO Series Navigator RCC PID3649 Add Study 10/1/2021 (Study date) RMLOLE Current RCCLE INSIGHT CEM_RML INSIGHT_CEM_RCC MG, 10/1/2021 n.a ., 6 mon ... Viewing Favorite Layouts MR DYN ReportFlow MR.Empty BASI Printing Tools Findings MR 5:36 PM Current Current US Clinical information 64-year-old female Second opinion from other centre Palpable mass Biopsy: Invasive ductal carcinoma (IDC) Luminal A MRI: Additional mass enhancement 6h (multicentric?) Healthineers PC.MLOICC MR.Dyna ... C.US | C .... Recombined 7 IMA 76 SL 2.2 mm SP F53.6 SPC 2.2 Zoom 1.49 BASIC SP F0.8 SP H23.4 SP H34.4 SP H19.0 SP F5.2 CEM Right MLO CC LowEnergy Pathology Additional lesion: Fibroadenoma Conclusion The additional lesion was a False Positive on MRI, but True Negative on TiCEM. MR.Dyn Sometimes IN2D images (= synthetic mammograms) are shown while verbally referring to the conventional mammograms. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. Results from case studies are not predictive of results in other cases. Results in other cases may vary. The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. Dr. Luis Pina is employed by an institution that receives financial support from Siemens Healthineers for collaborations. SIEMENS